Literature DB >> 10023333

AIDS vaccine development: let a thousand flowers bloom.

J S Oxford1, M Addawe, R Lambkin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 10023333      PMCID： PMC500925          DOI： 10.1136/jcp.51.10.725

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  28 in total

1.  Recombinant subunit vaccines as an approach to study correlates of protection against primate lentivirus infection.

Authors:  S L Hu; P Polacino; V Stallard; J Klaniecki; S Pennathur; B M Travis; L Misher; H Kornas; A J Langlois; W R Morton; R E Benveniste
Journal:  Immunol Lett       Date:  1996-06       Impact factor: 3.685

2.  An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous viruses.

Authors:  E Race; P Frezza; D M Stephens; D Davis; N Polyanskaya; M Cranage; J S Oxford
Journal:  Vaccine       Date:  1995-01       Impact factor: 3.641

3.  A multistep procedure for the chemical inactivation of human immunodeficiency virus for use as an experimental vaccine.

Authors:  E Race; C A Stein; M D Wigg; A Baksh; M Addawe; P Frezza; J S Oxford
Journal:  Vaccine       Date:  1995-11       Impact factor: 3.641

Review 4.  Toward an understanding of the correlates of protective immunity to HIV infection.

Authors:  B F Haynes; G Pantaleo; A S Fauci
Journal:  Science       Date:  1996-01-19       Impact factor: 47.728

5.  HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques.

Authors:  A G Abimiku; G Franchini; J Tartaglia; K Aldrich; M Myagkikh; P D Markham; P Chong; M Klein; M P Kieny; E Paoletti
Journal:  Nat Med       Date:  1995-04       Impact factor: 53.440

6.  Initial studies on active immunization of HIV-infected subjects using a gp120-depleted HIV-1 Immunogen: long-term follow-up.

Authors:  A M Levine; S Groshen; J Allen; K M Munson; D J Carlo; A E Daigle; F Ferre; F C Jensen; S P Richieri; R J Trauger; J W Parker; P L Salk; J Salk
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-04-01

Review 7.  DNA vaccines: a novel approach to immunization.

Authors:  E F Fynan; R G Webster; D H Fuller; J R Haynes; J C Santoro; H L Robinson
Journal:  Int J Immunopharmacol       Date:  1995-02

8.  A candidate live inactivatable attenuated vaccine for AIDS.

Authors:  B K Chakrabarti; R K Maitra; X Z Ma; H W Kestler
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

9.  Infection and AIDS in adult macaques after nontraumatic oral exposure to cell-free SIV.

Authors:  T W Baba; A M Trichel; L An; V Liska; L N Martin; M Murphey-Corb; R M Ruprecht
Journal:  Science       Date:  1996-06-07       Impact factor: 47.728

10.  Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients.

Authors:  N J Deacon; A Tsykin; A Solomon; K Smith; M Ludford-Menting; D J Hooker; D A McPhee; A L Greenway; A Ellett; C Chatfield; V A Lawson; S Crowe; A Maerz; S Sonza; J Learmont; J S Sullivan; A Cunningham; D Dwyer; D Dowton; J Mills
Journal:  Science       Date:  1995-11-10       Impact factor: 47.728
View more
  1 in total

Review 1.  A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

Authors:  David B Huang; Jashin J Wu; Stephen K Tyring
Journal:  J Infect       Date:  2004-10       Impact factor: 6.072
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.